trending Market Intelligence /marketintelligence/en/news-insights/trending/tpieum-cuka6cp33pcnfkq2 content esgSubNav
In This List

PolarityTE adds former US FDA, Johnson & Johnson executive as director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


PolarityTE adds former US FDA, Johnson & Johnson executive as director

PolarityTE Inc. has appointed Minnie Baylor-Henry to the board.

Previously, Baylor-Henry was a regulatory review officer, among other positions, at the U.S. Food and Drug Administration's Office of Regulatory Affairs. She was also vice president of U.S. regulatory affairs and medical affairs for specialty pharmaceuticals at Johnson & Johnson.

Salt Lake City-based PolarityTE is a biotechnology and regenerative biomaterials company.